Yahoo
Toronto - Delayed Quote CAD

Cronos Group Inc. (CRON.TO)

4.7600 +0.0600 (+1.28%)
At close: 4:00:00 PM EST
CRON.TO Q3 2026 earnings call
November 5, 2026 at 8:30 AM EST
Chart Range Bar
Loading chart for CRON.TO
  • Previous Close 4.7000
  • Open 4.7000
  • Bid 4.7400 x --
  • Ask 4.7600 x --
  • Day's Range 4.6800 - 4.8400
  • 52 Week Range 3.2300 - 4.9900
  • Volume 154,690
  • Avg. Volume 146,487
  • Market Cap (intraday) 1.754B
  • Beta (5Y Monthly) 1.25
  • PE Ratio (TTM) 18.31
  • EPS (TTM) 0.2600
  • Earnings Date Nov 5, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 5.93

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

thecronosgroup.com

610

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

CRON.TO
32.22%
S&P/TSX Composite index (^GSPTSE)
11.50%

1-Year Return

CRON.TO
34.84%
S&P/TSX Composite index (^GSPTSE)
17.42%

3-Year Return

CRON.TO
87.40%
S&P/TSX Composite index (^GSPTSE)
79.23%

5-Year Return

CRON.TO
30.61%
S&P/TSX Composite index (^GSPTSE)
67.09%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 74.38M
Earnings 45.02M
Profit Margin 60.53%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
20M
40M
60M
0.0%
20.0%
40.0%
60.0%

Analyst Insights

View More

Analyst Price Targets

4.20 Low
5.93 Average
4.7600 Current
7.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/13/2026
Analyst Zuanic & Associates
Rating Action Initiated
Rating Overweight
Price Action --
Price Target --

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    39.08%

  • Return on Assets (ttm)

    -0.10%

  • Return on Equity (ttm)

    7.05%

  • Revenue (ttm)

    179.09M

  • Net Income Avi to Common (ttm)

    69.98M

  • Diluted EPS (ttm)

    0.2600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    797.02M

  • Total Debt/Equity (mrq)

    0.12%

  • Levered Free Cash Flow (ttm)

    6.11M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: